We are driven forward by a vision of a future where cancer is curable.
Professor of Medicine, Chief Division of Gastroenterology
Physician and clinical researcher. Director of Gastroenterology outcomes Research and co-director of translational research education and careers in the Clinical and Translational Science Institute.
Co-Chair of the New York Citywide Colorectal Cancer Control Coalition risk assessment and screening committee. Former chair of the Diversity, Equity, and Inclusion Committee for the American College of Gastroenterology (ACG).
Head of Colorectal Cancer Screening Program
Former vice chair of the National Comprehensive Cancer Network guideline committees for genetic/high-risk familial assessment and screening for colorectal cancer.
Chief of the Department of Pathology at the Beth Israel Deaconess Medical Center (BIDMC); Specialized in diagnosing gastrointestinal diseases such as colorectal and pancreatic cancers.
Scientist/Entrepreneur.
Former Chairman DadeBehring Inc. US.
Medical Director. Head of Colorectal Cander Screening Program.
Director of the Institute of Oncology, ESMO President.
Medical Director. Center for Endoscopy UKE Hamburg; Member of Global Clinical Trial Board Epigenomics
Medical Director. Gastroenterology of Sana Klinikum Lichtenberg, Site Principal Investigator Germany; Member of Global Clinical Trial Board Epigenomics.
Colorectal Surgeon and Clinical Senior Lecturer in Colorectal Surgery. Member of Faculty of Medicine, Department of Surgery & Cancer at Imperial College London.
+140
CLINICAL INSTITUTIONS
10
Countries
We have built a network of >100 hospitals in the U.S. and across Europe with whom we have recruited >14K samples and work with more than hundred gastrointestinal clinical teams.
